PHAR
Pharming Group·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PHAR Filings
Filing Date
Form Description
Form Type
2025-11-06
Pharming Group N.V. (PHAR) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-06 · Earnings Call
Pharming Group N.V. (PHAR) Q3 2025 Earnings Call Transcript
2025-11-06
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-11-06 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-22
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-22 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-06
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-06 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-01
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-01 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-10
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-10 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-07-31
Pharming Group N.V. (PHAR) Q2 2025 Earnings Call Transcript
Earnings Call
2025-07-31 · Earnings Call
Pharming Group N.V. (PHAR) Q2 2025 Earnings Call Transcript
2025-07-31
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-07-31 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-06-24
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-06-24 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
